Pharmas Market with Mike Huckman

Genentech Earnings: Great Release Form, Not So Good Sales

Click for more earnings info

I know that a number of pharma and biotech PR people read this blog, so I wanted to hold up the Genentechearnings releaseas what I think is a great example of user-friendliness.

It is really heads and shoulders above the quarterly communications that come out of most of the companies I cover.

For example, check out the way they put the earnings per share numbers in a handy-dandy, easy-to-read graph:

Non-GAAP Diluted EPS
Employee Stock-Based Compensation Expense
Net Charges related to Redemption, Acquisition and Special Items
Reported GAAP Diluted EPS

Q1 2008$0.84